Compare MDXG & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | RNP |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 959.9M |
| IPO Year | 2007 | N/A |
| Metric | MDXG | RNP |
|---|---|---|
| Price | $4.94 | $21.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 793.8K | 151.3K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.94% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | $19.13 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.55 | ★ N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $4.87 | $19.00 |
| 52 Week High | $8.43 | $22.99 |
| Indicator | MDXG | RNP |
|---|---|---|
| Relative Strength Index (RSI) | 31.00 | 71.59 |
| Support Level | N/A | $21.20 |
| Resistance Level | $7.41 | $21.85 |
| Average True Range (ATR) | 0.19 | 0.28 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 11.85 | 87.70 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.